Remco Loos

Former Bristol Myers Squibb, Senior Director - Applied AI

  Seville, Andalusia, Spain

About me

Remco holds a PhD in computer science. He spent the initial part of his career in academia, in Cambridge, pursuing research in computational and single-cell biology. For the last decade, Remco has led teams in AI and data science in biotech and Pharma. He has contributed to 20+ clinical compounds across indications and modalities. His teams' research work has been presented at major AI/ML conferences (ICLR, NeurIPS).

Schedule

My Session

Accelerating Drug Discovery with AI: Breakthroughs, Challenges, and the Road Ahead

Remco Loos

Former Bristol Myers Squibb, Senior Director - Applied AI


AI-Driven Innovation
Drug Discovery and Development
Panel Discussion: AI and Automation in Drug Discovery: From Hype to Real-World Breakthroughs – Can Innovation Keep Up with Regulation?
  • How close are we to AI-designed drugs reaching patients — and what’s still missing in validation and translation?
  • Are global frameworks agile enough to assess and approve discoveries driven by algorithms?
  • What real-world examples reveal the difference between AI hype and genuine productivity gains in discovery?
  • When AI suggests a molecule or pathway, who takes responsibility if it fails — the scientist, the system, or the sponsor?
  • How will AI, quantum computing, and automation converge to redefine timelines, talent, and trust in the pharma R&D ecosystem?

AI-Driven Innovation
Regulatory and Ethical Considerations

Konrad Dobschuetz

Founder Director at Leap Advisory & Intelligence

Olga Obrezanova

AI Principal Scientist at AstraZeneca

Frederik Buijs

Senior Medical Director at Roche

Esben Jannik Bjerrum

Principal Research Scientist II, AI / ML Team Lead at AbbVie

Mohammad Hassan Khalid

Head of AI/ML at Portal Biotech Ltd

Remco Loos

Former Bristol Myers Squibb, Senior Director - Applied AI